Clinical trial
Prospective, Non-Randomized, Multi-Center, Single-Arm Trial to Assess Safety & Efficacy of the Acculink Carotid Stent System With the Accunet Embolic Protection System in High-Risk Patients With Carotid Artery Lesions.
NCT00180518 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Non-Randomized, Multi-Center, Single-Arm Trial to Assess Safety & Efficacy of the Acculink Carotid Stent System With the Accunet Embolic Protection System in High-Risk Patients With Carotid Artery Lesions.
- Lead sponsor
- Abbott Medical Devices
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 31, 2000
- Completion date
- November 30, 2003
- Enrollment
- 581
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
carotid artery disease, carotid atherosclerosis